HSCT: Clinical Trials

4 trials for HSCT, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 recruiting, 1 unknown. 4 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 1, Not yet recruiting 1, Recruiting 1, Unknown 1

Follow HSCT: new trials by email Literature Review of HSCT trials Research Report on HSCT

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Efficacy and Safety of Stereotactic Radiotherapy Bridging Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignance Patients With Extramedullary Infiltrating
Stereotactic body radiotherapy (SBRT) - HSCT, Hematologic Cancer
Not applicableNot yet recruitingInstitute of Hematology & Blood Diseases Hospital, China202026-04-142026-03-06
Comparison of Intralipid With SMOF Lipid Following HSCT
SMOF lipid, INTRALIPIDS - Leukemia, HSCT
Not applicableRecruitingShahid Beheshti University502024-10-122024-10-16
Patient Reported Outcomes and Patient Education in Cellular Therapy Patients
Education - Stem Cell Transplant, CAR T-Cell Transplant
Not applicableCompletedDartmouth-Hitchcock Medical Center312021-02-072023-11-22
Efficacy and Safety of Azacitidine Combined With Interferon in the Treatment of Post-transplant Recurrence
Azacitidine combined with interferon preemptive treatment - HSCT, Efficacy and Safety
Not applicableUnknownShanghai General Hospital, Shanghai Jiao Tong University School of Medicine302019-08-282020-10-27

Narrower conditions

Leukemia (2)  ·  Hematologic Neoplasms (1)  ·  Lymphoma (1)  ·  Multiple Myeloma (1)

Broader conditions

Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (2)  ·  Blood Protein Disorders (1)  ·  Cardiovascular Diseases (1)  ·  Hemorrhagic Disorders (1)  ·  Hemostatic Disorders (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Plasma Cell (1)  ·  Paraproteinemias (1)

Interventions

Educational Status (1)  ·  Radiosurgery (1)

Sponsors

Dartmouth-Hitchcock Medical Center (1)  ·  Institute of Hematology & Blood Diseases Hospital, China (1)  ·  Shahid Beheshti University (1)  ·  Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1)

Countries

China (1)  ·  Iran (1)  ·  United States (1)

Top investigators

Xianmin Song, M.D (1)  ·  Zahra Vahdat Shariatpanahi, Professor (1)